((自动化翻译由路透提供，请见免责声明 ))
9月18日 - ** 医疗设备制造商爱德华生命科学 股价盘前下跌1.6%至66.14美元
** 杰富瑞将EW的评级从 "买入 "下调至 "持有"，并将该公司的目标价从85美元下调至70美元
** 券商预计近期增长仍将受到竞争加剧、价格压力和工作流程挑战的制约。
** EW 一直在苦苦挣扎， (link)，其用于微创心脏手术的人工心脏瓣膜需求疲软。
** 券商称，预计下半年增长将 "同样受限"。
** 32家券商的平均评级接近于 "持有"，中位PT为75.50美元 - LSEG
** 截至上次收盘，该股今年累计下跌约 12
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.